Pancreatic Cancer Research

ResearcherNankai UniversityNo recent work listed

Xiaohong Shen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4714-0831; OpenAlex author ID A5061330880. Sources: OpenAlex.

Their work

Papers
16 (first author 0, last author 16)
Trials
0
Grants
0
Labs led
1
Collaborators
13
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: 3 papers · 2017: 2 papers · 2018: 2 papers · 2019: none · 2020: 3 papers · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper

Papers 16

  1. Apolipoprotein E2 inhibits mitochondrial apoptosis in pancreatic cancer cells through ERK1/2/CREB/BCL-2 signaling. Last author DOI 10.1016/j.hbpd.2022.09.010↗
  2. COL11A1-Driven Epithelial-Mesenchymal Transition and Stemness of Pancreatic Cancer Cells Induce Cell Migration and Invasion by Modulating the AKT/GSK-3β/Snail … Last author DOI 10.3390/biom12030391↗
  3. The COL11A1/Akt/CREB signaling axis enables mitochondrial-mediated apoptotic evasion to promote chemoresistance in pancreatic cancer cells through modulating B… Last author DOI 10.7150/jca.47032↗
  4. LAMC2 modulates the acidity of microenvironments to promote invasion and migration of pancreatic cancer cells via regulating AKT-dependent NHE1 activity. Last author DOI 10.1016/j.yexcr.2020.111984↗
  5. Apolipoprotein E2 modulates cell cycle function to promote proliferation in pancreatic cancer cells via regulation of the c-Myc-p21Waf1 signalling pathway. Last author DOI 10.1139/bcb-2018-0230↗
  6. Apolipoprotein E2 Promotes the Migration and Invasion of Pancreatic Cancer Cells via Activation of the ERK1/2 Signaling Pathway. Last author DOI 10.2147/cmar.s284115↗
  7. Artemin regulates CXCR4 expression to induce migration and invasion in pancreatic cancer cells through activation of NF-κB signaling. Last author DOI 10.1016/j.yexcr.2018.02.008↗
  8. Tenascin-C Modulates Cell Cycle Progression to Enhance Tumour Cell Proliferation through AKT/FOXO1 Signalling in Pancreatic Cancer. Last author DOI 10.7150/jca.25926↗
  9. Fractalkine/CX3CR1 induces apoptosis resistance and proliferation through the activation of the AKT/NF-κB cascade in pancreatic cancer cells. Last author DOI 10.1002/cbf.3278↗
  10. Tenascin-C induces migration and invasion through JNK/c-Jun signalling in pancreatic cancer. Last author DOI 10.18632/oncotarget.20160↗
  11. Nerve growth factor regulates CD133 function to promote tumor cell migration and invasion via activating ERK1/2 signaling in pancreatic cancer. Last author DOI 10.1016/j.pan.2016.09.005↗
  12. Gastrin regulates ABCG2 to promote the migration, invasion and side populations in pancreatic cancer cells via activation of NF-κB signaling. Last author DOI 10.1016/j.yexcr.2016.06.001↗
  13. Hypoxia regulates ABCG2 activity through the activivation of ERK1/2/HIF-1α and contributes to chemoresistance in pancreatic cancer cells. Last author DOI 10.1080/15384047.2016.1139228↗
  14. Tenascin-C induces resistance to apoptosis in pancreatic cancer cell through activation of ERK/NF-κB pathway. Last author DOI 10.1007/s10495-015-1106-4↗
  15. The roles of Wnt5a, JNK and paxillin in the occurrence of metastasis of pancreatic adenocarcinoma. Last author DOI 10.1007/s10147-013-0648-0↗
  16. WNT5A/JNK signaling regulates pancreatic cancer cells migration by Phosphorylating Paxillin. Last author DOI 10.1016/j.pan.2013.05.008↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hui Wang · 10 shared papers, 2017–2023 · strength 1.34
  2. Shaoxia Du · 9 shared papers, 2017–2023 · strength 1.11
  3. Jun Cai · 9 shared papers, 2016–2021 · strength 0.96
  4. Beibei Xin · 6 shared papers, 2016–2018 · strength 0.43
  5. Juan Wang · 4 shared papers, 2016–2020 · strength 0.37
  6. Wei Wei · 3 shared papers, 2016–2020 · strength 0.26
  7. Xiaodan He · 4 shared papers, 2015–2016 · strength 0.26
  8. Wei Wei · 2 shared papers, 2013–2020 · strength 0.19
  9. Meiyan Shi · 2 shared papers, 2015–2016 · strength 0.13
  10. Juan Wang · 1 shared paper, 2015 · strength 0.06
  11. Wei Wei · 1 shared paper, 2014 · strength 0.05
  12. Wenli Lu · 1 shared paper, 2014 · strength 0.05
  13. Qiang Li · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.